Our Phase II, III and IV clinical studies are completed in the central building of DRC in strict compliance with applicable GCP regulations.
As a result of our past operation we have gained wide experience in clinical trials involving conventional products, small molecules, and biological or bio-similar drug candidates.
Until now we have successfully completed more than 75 Phase II, around 200 Phase III and 20 Phase IV trials. For your request we will provide you with a list of references.
Recruitment of patients is supported by our expanding database. By using database, patients can be selected with great security and speed.
Clinical Trials for medical devices:
In light of new legal requirements DRC welcomes request to deliver clinical trials for clinical